SILAC-Based Quantitative Proteomic Analysis of Diffuse Large B-Cell Lymphoma Patients

Figure 3

A supervised partial least-squares regression analysis (PLS-DA) including five selected proteins involved in actin cytoskeleton (moesin, CAP1, CAPG, annexin A6, and PDCD4) discriminates the two patient groups. Green dots are patients 1–5 (early relapse/refractory patients) while blue dots are patients 6–10 (progression-free patients).